Cargando…
Alone laser versus bevacizumab plus laser for diffuse diabetic macular edema (ALBA randomized trial)
PURPOSE: To report the 12-month results of laser (treatment G1) versus intravitreal bevacizumab combined with laser (treatment G2) in patients with diffuse diabetic macular edema (DME). METHODS: In this single-center randomized independent controlled trial, 32 patients were randomized to G1 (n = 15)...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812399/ https://www.ncbi.nlm.nih.gov/pubmed/33506177 http://dx.doi.org/10.1177/2515841420988210 |